Product Pipeline
ImVisioN is using its proprietary intralymphatic immunotherapy (ILIT ™) and Modular-Antigen-Transportation ™
(MAT ™) technologies to generate a pipeline of allergy treatments that are safer, more efficacious and more convenient for the patient. Currently, ImVisioN has a lead product, IVN201 and two programes addressing birch pollen allergy and house dust mite allergy.
- Type text here -
